'No Need For Panic' On Pharma IP Front Post Brexit Vote
This article was originally published in SRA
Executive Summary
Pharmaceutical companies worried about how the UK's vote to leave the EU will affect their IP rights are being advised to 'keep calm and carry on' as instruments for securing patent protection in the UK will remain unaffected by the departure.